{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:11:11Z","timestamp":1768313471351,"version":"3.49.0"},"reference-count":62,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Morris L Lichtenstein Jr Medical Research Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Western diets contribute to metabolic diseases. However, the effects of various diets and epigenetic mechanisms are mostly unknown. Here, six week-old C57BL\/6J male and female mice were fed with a low-fat diet (LFD), high-fat diet (HFD), and high-fat high-fructose diet (HFD-HF) for 20 weeks. We determined that HFD-HF or HFD mice experienced significant metabolic dysregulation compared to the LFD. HFD-HF and HFD-fed male mice showed significantly increased body weight, liver size, and fasting glucose levels with downregulated PPAR\u03b3, SCD1, and FAS protein expression. In contrast, female mice were less affected by HFD and HFD-HF. As miR-27b contains a seed sequence in PPAR\u03b3, it was discovered that these changes are accompanied by male-specific upregulation of miR-27b-5p, which is even more pronounced in the HFD-HF group (p &lt; 0.01 vs. LFD) compared to the HFD group (p &lt; 0.05 vs. LFD). Other miR-27 subtypes were increased but not significantly. HFD-HF showed insignificant changes in fibrosis markers when compared to LFD. Interestingly, fat ballooning in hepatocytes was increased in HFD-fed mice compared to HFD-HF fed mice, however, the HFD-HF liver showed an increase in the number of small cells. Here, we concluded that chronic Western diet-composition administered for 20 weeks may surpass the non-alcoholic fatty liver (NAFL) stage but may be at an intermediate stage between fatty liver and fibrosis via miR-27b-5p-induced PPAR\u03b3 downregulation.<\/jats:p>","DOI":"10.3390\/ijms22041822","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T18:45:00Z","timestamp":1613155500000},"page":"1822","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-\u03b3 Pathway via miR-27b-5p Regulation"],"prefix":"10.3390","volume":"22","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[{"name":"Pharmaceutical Sciences, Texas A&amp;M Health Science Center, College Station, TX 77843, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A","family":"Powell","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Texas A&amp;M Health Science Center, College Station, TX 77843, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew K","family":"Kay","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Texas A&amp;M Health Science Center, College Station, TX 77843, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Sonkar","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Texas A&amp;M Health Science Center, College Station, TX 77843, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunitha","family":"Meruvu","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Texas A&amp;M Health Science Center, College Station, TX 77843, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahua","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Texas A&amp;M Health Science Center, College Station, TX 77843, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-0298","article-title":"Type 2 Diabetes: An Epidemic Requiring Global Attention and Urgent Action","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00019501-200602000-00013","article-title":"The metabolic syndrome: A call to action","volume":"17","author":"Gotto","year":"2006","journal-title":"Coron. Artery Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1942648","DOI":"10.1155\/2018\/1942648","article-title":"Steatohepatitis is not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease","volume":"2018","author":"Hagstrom","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.3748\/wjg.v21.i39.11077","article-title":"Liver fibrosis in non-alcoholic fatty liver disease-diagnostic challenge with prognostic significance","volume":"21","author":"Stal","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/oby.21371","article-title":"Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome","volume":"24","author":"Lustig","year":"2016","journal-title":"Obesity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","article-title":"Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study","volume":"47","author":"Goldsmith","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","article-title":"Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake","volume":"138","author":"Thuy","year":"2008","journal-title":"J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.24148","article-title":"Nuclear receptors in liver disease","volume":"53","author":"Wagner","year":"2011","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00018-018-2838-4","article-title":"Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation","volume":"75","author":"Silva","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.25880","article-title":"Analysis of the Role of Hepatic PPARg Expression during Mouse Liver Regeneration","volume":"56","author":"Gazit","year":"2012","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/mmr.2014.2846","article-title":"microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor gamma","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"86198","DOI":"10.18632\/oncotarget.13365","article-title":"Suppression of hepatic stellate cell activation through downregulation of gremlin1 expression by the miR-23b\/27b cluster","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-g","volume":"1","author":"Povero","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Povero, D., Eguchi, A., Li, H., Johnson, C.D., Papouchado, B.G., Wree, A., Messer, K., and Feldstein, A.E. (2014). Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113651"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2016.11.009","article-title":"PPARs and nonalcoholic fatty liver disease","volume":"136","author":"Liss","year":"2017","journal-title":"Biochimie"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: Basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/nu7042748","article-title":"Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome","volume":"7","author":"Chango","year":"2015","journal-title":"Nutrients"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1074\/jbc.M310284200","article-title":"Peroxisome proliferatoractivated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells","volume":"279","author":"Hazra","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jnc.14208","article-title":"MicroRNA-27a-3p suppression of peroxisome proliferator-activated receptor-gamma contributes to cognitive impairments resulting from sevoflurane treatment","volume":"143","author":"Lv","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/jcm4121953","article-title":"MicroRNAs in Nonalcoholic Fatty Liver Disease","volume":"4","author":"Baffy","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.1073\/pnas.1905172116","article-title":"HuR counteracts miR-330 to promote STAT3 translation during inflammation-induced muscle wasting","volume":"116","author":"Mubaid","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1073\/pnas.0707594105","article-title":"MicroRNA-373 induces expression of genes with complementary promoter sequences","volume":"105","author":"Place","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2015.08.012","article-title":"MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARg expression: A rat fibrosis model study","volume":"465","author":"Lu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/rna.27655","article-title":"Combinatorial regulation of lipoprotein lipase by microRNAs during mouse adipogenesis","volume":"11","author":"John","year":"2014","journal-title":"RNA Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.1038\/s41598-019-50210-3","article-title":"MicroRNA-27a\/b-3p and PPARG regulate SCAMP3 through a feed-forward loop during adipogenesis","volume":"9","author":"Kulyte","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Del Campo, J.A., Gallego-Duran, R., Gallego, P., and Grande, L. (2018). Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD). Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030911"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E203","DOI":"10.1152\/ajpendo.00076.2017","article-title":"Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver","volume":"313","author":"Chukijrungroat","year":"2017","journal-title":"Am. J. Physiol. Endocr. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","article-title":"Increased adipose tissue in male and female estrogen receptor-alpha knockout mice","volume":"97","author":"Heine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ijo.2011.87","article-title":"Sex differences during the course of diet-induced obesity in mice: Adipose tissue expandability and glycemic control","volume":"36","author":"Medrikova","year":"2012","journal-title":"Int. J. Obes."},{"key":"ref_39","first-page":"514","article-title":"Obesity in rhesus and cynomolgus macaques: A comparative review of the condition and its implications for research","volume":"61","author":"Bauer","year":"2011","journal-title":"Comp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-6147(02)00051-2","article-title":"Obesity\u2014A chronic health problem in cloned mice?","volume":"24","author":"Inui","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12986-018-0243-5","article-title":"The common use of improper control diets in diet-induced metabolic disease research confounds data interpretation: The fiber factor","volume":"15","author":"Pellizzon","year":"2018","journal-title":"Nutr. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/505612a","article-title":"NIH calls for increased rigor and reproducibility","volume":"2014","author":"Collins","year":"2014","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"F812","DOI":"10.1152\/ajprenal.00265.2015","article-title":"Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance","volume":"310","author":"Nizar","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ejcn.2014.8","article-title":"Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials","volume":"68","author":"Chiu","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00394-016-1340-8","article-title":"A review of recent evidence relating to sugars, insulin resistance and diabetes","volume":"55","author":"Macdonald","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease","volume":"124","author":"Ipsen","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"757803","DOI":"10.1155\/2012\/757803","article-title":"PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs","volume":"2012","author":"Peyrou","year":"2012","journal-title":"PPAR Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14493","DOI":"10.1038\/s41598-017-15141-x","article-title":"MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes","volume":"111","author":"Matsusue","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_51","first-page":"505","article-title":"Expression of fatty acid synthase in nonalcoholic fatty liver disease","volume":"3","author":"Dorn","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gianotti, T.F., Burgue\u00f1o, A., Mansilla, N.G., Pirola, C.J., and Sookoian, S. (2013). Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076912"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-007-0738-5","article-title":"Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice","volume":"50","author":"Toye","year":"2007","journal-title":"Diabetologia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.metabol.2016.01.011","article-title":"Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity","volume":"65","author":"Walle","year":"2016","journal-title":"Metabolism"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/liv.13302","article-title":"Therapies in non-alcoholic steatohepatitis (NASH)","volume":"37","author":"Oseini","year":"2017","journal-title":"Liver Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Dongiovanni, P., Meroni, M., Longo, M., Fargion, S., and Fracanzani, A.L. (2018). miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123966"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4254\/wjh.v7.i2.226","article-title":"Micro RNAs in the development of non-alcoholic fatty liver disease","volume":"7","author":"Gerhard","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00024.2019","article-title":"Advancing metabolism research to overcome low litter survival in metabolically stressed mice","volume":"317","author":"Powell","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1021\/acs.chemrestox.6b00038","article-title":"Mono-(2-ethylhexyl) Phthalate Increases Oxidative Stress Responsive miRNAs in First Trimester Placental Cell Line HTR8\/SVneo","volume":"29","author":"Meruvu","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tiv.2016.11.016","article-title":"The plasticizer BBP selectively inhibits epigenetic regulator sirtuin during differentiation of C3H10T1\/2 stem cell line","volume":"39","author":"Zhang","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tiv.2015.11.010","article-title":"Mono-(2-ethylhexyl) phthalate induces apoptosis through miR-16 in human first trimester placental cell line HTR-8\/SVneo","volume":"31","author":"Meruvu","year":"2016","journal-title":"Toxicol. In Vitro"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1822\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:23:15Z","timestamp":1760160195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22041822"],"URL":"https:\/\/doi.org\/10.3390\/ijms22041822","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}